Posted on 10/5/18
Qfix Partners with Apollo Hospitals India
Apollo Hospitals and Qfix jointly announce a partnership that will allow Indian proton therapy patients to benefit from the very latest in patient-positioning and fixation technology. . . .
Posted on 10/3/18
Eagle Pharmaceuticals Enters into Agreement with USAMRICD
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) today announced that it has entered into an agreement with the United States Army Medical Research Institute of . . .
Posted on 10/3/18
ADMA BioCenters Receives FDA Approval for Third Plasma Collection Center
RAMSEY, N.J. and MARIETTA, Ga., Oct. 03, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA), a vertically integrated commercial biopharmaceutical company that develops, manufactures and . . .
Posted on 10/3/18
Pfizer: Stay The Course
SummaryNew CEO coming on board.His experience lies in innovation.We expect Pfizer to become more focused after the transition especially on acquisitions.Remaining long.Looking for a portfolio of . . .
Posted on 10/3/18
Cognition Therapeutics Receives $16.6 Million Multiyear NIA Grant
Pittsburgh, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on synaptic health and restoration in Alzheimer’s disease and other . . .
Posted on 10/3/18
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
WAYNE, Pa., Oct. 02, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a dermatologist-led biopharmaceutical company focused on identifying, developing, and commercializing innovative therapies to . . .
Posted on 10/2/18
Dr. Reddy's Laboratories Announces the Sale of Cloderm Cream, 0.1% Franchise to EPI Health
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. announced today that its wholly owned subsidiary Promius Pharma, LLC, has sold its rights of Cloderm Cream, . . .
Posted on 10/2/18
FierceBiotech Names Tmunity as One of Its “Fierce 15” Biotech Companies of 2018
PHILADELPHIA--(BUSINESS WIRE)--Tmunity Therapeutics, Inc., a private clinical-stage biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T cell immunotherapy, today . . .
Posted on 10/2/18
Johnson & Johnson Completes Divestiture Of LifeScan Business To Platinum Equity
Johnson & Johnson (NYSE:JNJ) has completed the divestiture of its LifeScan business to Platinum Equity for ~$2.1B.JNJ will discuss this transaction during its scheduled quarterly earnings . . .
Posted on 10/2/18
Pfizer Snatches FDA Approval For Rare Front-Line Lung Cancer Indication
SummaryPfizer receives FDA approval for Vizimpro which treats a rare form of lung cancer.With the latest FDA approval for Vizimpro, Pfizer now has two drugs that . . .
Posted on 10/2/18
Teva Pharmaceutical Stock Wins 2 Upgrades: What You Need to Know
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking . . .
Posted on 10/1/18
Hitachi Chemical Advanced Therapeutics Solutions Signs Three-Year Agreement with GSK
ALLENDALE, N.J.--(BUSINESS WIRE)--Hitachi Chemical Advanced Therapeutics Solutions, LLC (HCATS) announced today that they have signed a three-year clinical manufacturing agreement with GSK, a science-led global healthcare . . .
Posted on 10/1/18
Dr. Reddy's Laboratories Sells Its Antibiotic Manufacturing Site and Its Related Assets in Bristol, Tennessee
Dr. Reddy’s Laboratories Ltd. today announced the closure of the sale of its antibiotic manufacturing facility and related assets in Bristol, Tennessee to Neopharma Inc
Posted on 10/1/18
Better Buy: Novavax, Inc. vs. Pfizer Inc.
On paper, there's really no contest between Novavax, Inc. (NASDAQ:NVAX) and Pfizer Inc.(NYSE:PFE). Novavax has no approved products. It doesn't have a steady source of revenue. . . .
Posted on 10/1/18
Pfizer: Where's The Stock Headed?
SummaryPfizer is heading toward an important, very long-term resistance level.We look at the technical side of Pfizer's stock history to see if there are any hints . . .
Posted on 10/1/18
Can Geron Corporation Recover From Its Breakup With Johnson & Johnson?
Plenty of biotech investors have been feeling distraught after Johnson & Johnson (NYSE:JNJ)walked away from a four-year relationship with Geron Corporation (NASDAQ:GERN) despite several nuggets of . . .
Posted on 9/30/18
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on September 25, 2018 it approved non-statutory stock options to purchase an aggregate of 122,200 shares of its . . .
Posted on 10/4/18
Certara Launches BaseCase Portal, Delivers Therapeutic Decision-making Apps to HCPs at POC
BaseCase Portal allows life sciences companies to rapidly deploy mobile apps that use advanced predictive algorithms to individualize patient treatment by making precision-dosing recommendations for example . . .
Posted on 9/27/18
Quest Diagnostics Acquires PhenoPath
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has acquired PhenoPath
Posted on 9/26/18
Nutrisystem Named to Soaring 76 List of Fastest-Growing Companies by the Philadelphia Business Journal For Second Consecutive Year
HILADELPHIA--(BUSINESS WIRE)--Nutrisystem, Inc. (Nasdaq: NTRI) a leading provider of health and wellness and weight management products and services including Nutrisystem® and South Beach Diet® brands, has . . .
Posted on 9/26/18
Merck Board Rescinds Mandatory CEO Retirement Policy
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that its Board of Directors has rescinded its policy subjecting . . .
Posted on 9/26/18
PANTHERx Specialty Pharmacy Named 2018 Specialty Pharmacy of the Year by the National Association of Specialty Pharmacy
PANTHERx® Specialty Pharmacy, THE Rare Disease SP®, announces that is has been named 2018 Specialty Pharmacy of the Year by the National Association of Specialty Pharmacy . . .
Posted on 9/26/18
Onconova Therapeutics Announces Reverse Stock Split
NEWTOWN, Pa., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (Nasdaq: ONTX), a Phase 3 stage biopharmaceutical company focused on developing rigosertib, a novel small . . .
Posted on 9/26/18
Cancer Genetics Enters Supply Agreement with Agilent Technologies
RUTHERFORD, N.J., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers . . .
Posted on 9/25/18
Quest Diagnostics to Acquire U.S. Laboratory Services Business of Oxford Immunotec
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Oxford Immunotec Global PLC (Nasdaq: OXFD)

